BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BPMC

<< 前へ 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/06/07	21 : 43	TipRanks	Where Does Blueprint Medicines Stand Ahead of Anticipated FDA Decision on Avapritinib?	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 15	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/05	05 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/06/04	05 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/25	21 : 00	PR Newswire (US)	Blueprint Medicines to Present at Upcoming Investor Conferences	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/22	05 : 24	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/20	06 : 00	PR Newswire (US)	Blueprint Medicines Presents ARROW Trial Data for GAVRETO® (pralsetinib) Highlighting Durable Clinical Activity in Patients ...	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/17	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/17	21 : 00	PR Newswire (US)	Blueprint Medicines Appoints Percy Carter, MBA, Ph.D., as Chief Scientific Officer	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/15	07 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/05/06	05 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/30	05 : 20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/29	20 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/29	20 : 00	PR Newswire (US)	Blueprint Medicines Reports First Quarter 2021 Financial Results	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/22	21 : 00	PR Newswire (US)	Blueprint Medicines to Report First Quarter 2021 Financial Results on Thursday, April 29, 2021	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/22	05 : 35	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/22	05 : 31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/12	20 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/12	03 : 00	PR Newswire (US)	Blueprint Medicines Data Highlight Clinical Leadership in Systemic Mastocytosis at AACR Annual Meeting 2021	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/10	21 : 30	PR Newswire (US)	Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2...	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/08	05 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/04/05	21 : 00	PR Newswire (US)	Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday,...	NASDAQ:BPMC	Blueprint Medicines Corporation
2021/03/18	06 : 49	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:BPMC	Blueprint Medicines Corporation